125 related articles for article (PubMed ID: 38846358)
1. Emergence of Erythromycin-Resistant and Pertactin- and Filamentous Hemagglutinin-Deficient
Zhou G; Li Y; Wang H; Wang Y; Gao Y; Xu J; Wang F; Peng T; Zhang M; Shao Z
China CDC Wkly; 2024 May; 6(20):437-441. PubMed ID: 38846358
[TBL] [Abstract][Full Text] [Related]
2. A Cross-Sectional Study Revealing the Emergence of Erythromycin-Resistant
Wu X; Du Q; Li D; Yuan L; Meng Q; Fu Z; Xu H; Yao K; Zhao R
Front Microbiol; 2022; 13():901617. PubMed ID: 35923401
[TBL] [Abstract][Full Text] [Related]
3. Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959-2013.
Mosiej E; Zawadka M; Krysztopa-Grzybowska K; Polak M; Augustynowicz E; Piekarska K; Lutyńska A
Eur J Clin Microbiol Infect Dis; 2015 Jan; 34(1):147-152. PubMed ID: 25090968
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology of Bordetella pertussis and analysis of vaccine antigen genes from clinical isolates from Shenzhen, China.
Wu S; Hu Q; Yang C; Zhou H; Chen H; Zhang Y; Jiang M; He Y; Shi X
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):53. PubMed ID: 34407803
[TBL] [Abstract][Full Text] [Related]
5. Emergence and spread of MT28 ptxP3 allele macrolide-resistant Bordetella pertussis from 2021 to 2022 in China.
Fu P; Zhou J; Meng J; Liu Z; Nijiati Y; He L; Li C; Chen S; Wang A; Yan G; Lu G; Zhou L; Zhai X; Wang C
Int J Infect Dis; 2023 Mar; 128():205-211. PubMed ID: 36632892
[TBL] [Abstract][Full Text] [Related]
6. Molecular Evolution and Increasing Macrolide Resistance of Bordetella pertussis, Shanghai, China, 2016-2022.
Fu P; Zhou J; Yang C; Nijiati Y; Zhou L; Yan G; Lu G; Zhai X; Wang C
Emerg Infect Dis; 2023 Jan; 30(1):29-38. PubMed ID: 38146984
[TBL] [Abstract][Full Text] [Related]
7. Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.
Polak M; Zasada AA; Mosiej E; Krysztopa-Grzybowska K; Witkowski L; Rzeczkowska M; Piekarska K; Lutyńska A
Microbes Infect; 2019; 21(3-4):170-175. PubMed ID: 30580013
[TBL] [Abstract][Full Text] [Related]
8. Domination of an emerging erythromycin-resistant ptxP3 Bordetella pertussis clone in Shanghai, China.
Cai J; Chen M; Liu Q; Luo J; Yuan L; Chen Y; Chen M; Zeng M
Int J Antimicrob Agents; 2023 Jul; 62(1):106835. PubMed ID: 37127126
[TBL] [Abstract][Full Text] [Related]
9. Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014).
Yang Y; Yao K; Ma X; Shi W; Yuan L; Yang Y
PLoS One; 2015; 10(9):e0138941. PubMed ID: 26406905
[TBL] [Abstract][Full Text] [Related]
10. Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis.
Weigand MR; Pawloski LC; Peng Y; Ju H; Burroughs M; Cassiday PK; Davis JK; DuVall M; Johnson T; Juieng P; Knipe K; Loparev VN; Mathis MH; Rowe LA; Sheth M; Williams MM; Tondella ML
Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29358336
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial susceptibility and antigen genotypes of Bordetella pertussis strains isolated from neonates].
Li LJ; Liu Y; Jia J; Yuan L; Shi W; Meng QH; Yao KH
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Mar; 21(3):208-213. PubMed ID: 30907341
[TBL] [Abstract][Full Text] [Related]
12. Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013-2017.
Xu Z; Octavia S; Luu LDW; Payne M; Timms V; Tay CY; Keil AD; Sintchenko V; Guiso N; Lan R
Emerg Infect Dis; 2019 Jun; 25(6):1196-1199. PubMed ID: 31107218
[TBL] [Abstract][Full Text] [Related]
13. Emerging of ptxP3 lineage in Bordetella pertussis strains circulating in a population in northeastern Mexico.
Gutiérrez-Ferman JL; Villarreal-Treviño L; Ramírez-Aranda JM; Camacho-Ortiz A; Ballesteros-Elizondo MR; Moreno-Juárez MR; Mendoza-Olazarán S; de la O Cavazos ME; Villarreal-Pérez JZ; Gómez-Govea MA; Garza-González E
Epidemiol Infect; 2018 Dec; 146(16):2096-2101. PubMed ID: 30136639
[TBL] [Abstract][Full Text] [Related]
14. A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines.
Barkoff AM; Guiso N; Guillot S; Xing D; Markey K; Berbers G; Mertsola J; He Q
J Immunol Methods; 2014 Jun; 408():142-8. PubMed ID: 24925807
[TBL] [Abstract][Full Text] [Related]
15. Bordetella pertussis Infection in Infants and Young Children in Shanghai, China, 2016-2017: Clinical Features, Genotype Variations of Antigenic Genes and Macrolides Resistance.
Fu P; Wang C; Tian H; Kang Z; Zeng M
Pediatr Infect Dis J; 2019 Apr; 38(4):370-376. PubMed ID: 30882726
[TBL] [Abstract][Full Text] [Related]
16. Evolution of
Bouchez V; Guillot S; Landier A; Armatys N; Matczak S; ; Toubiana J; Brisse S
Euro Surveill; 2021 Sep; 26(37):. PubMed ID: 34533118
[TBL] [Abstract][Full Text] [Related]
17. High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016.
Li L; Deng J; Ma X; Zhou K; Meng Q; Yuan L; Shi W; Wang Q; Li Y; Yao K
Emerg Infect Dis; 2019 Dec; 25(12):2205-2214. PubMed ID: 31742507
[TBL] [Abstract][Full Text] [Related]
18. Pertactin-deficient
Barkoff AM; Mertsola J; Pierard D; Dalby T; Hoegh SV; Guillot S; Stefanelli P; van Gent M; Berbers G; Vestrheim D; Greve-Isdahl M; Wehlin L; Ljungman M; Fry NK; Markey K; He Q
Euro Surveill; 2019 Feb; 24(7):. PubMed ID: 30782265
[TBL] [Abstract][Full Text] [Related]
19. Macrolide susceptibility and molecular characteristics of
Zhang J; Zhang D; Wang X; Wei X; Li H
J Int Med Res; 2022 Feb; 50(2):3000605221078782. PubMed ID: 35225710
[TBL] [Abstract][Full Text] [Related]
20. Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina.
Carriquiriborde F; Regidor V; Aispuro PM; Magali G; Bartel E; Bottero D; Hozbor D
Emerg Infect Dis; 2019 Nov; 25(11):2048-2054. PubMed ID: 31625838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
